Get the Stockscreener App
17.49
0.98%
0.17
After Hours:
13.99
-3.50
-20.01%
Quidelortho Corporation stock is traded at $17.49, with a volume of 1.76M.
It is up +0.98% in the last 24 hours and up +2.28% over the past month.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
See More
Previous Close:
$17.32
Open:
$17.52
24h Volume:
1.76M
Relative Volume:
1.18
Market Cap:
$1.19B
Revenue:
$2.73B
Net Income/Loss:
$-1.13B
P/E Ratio:
-1.0497
EPS:
-16.6622
Net Cash Flow:
$-83.00M
1W Performance:
+14.16%
1M Performance:
+2.28%
6M Performance:
-35.96%
1Y Performance:
-34.15%
1-Day Range:
$17.26
$18.00
1-Week Range:
$13.70
$18.00
52-Week Range:
$13.70
$38.99
Quidelortho Corporation Stock (QDEL) Company Profile
Name
Quidelortho Corporation
Sector
Industry
Phone
(858) 552-1100
Address
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corporation
|
17.49 | 1.18B | 2.73B | -1.13B | -83.00M | -16.66 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-07-25 | Downgrade | Citigroup | Buy → Neutral |
| May-08-25 | Upgrade | Jefferies | Hold → Buy |
| Dec-11-24 | Upgrade | Citigroup | Neutral → Buy |
| Dec-10-24 | Initiated | Jefferies | Hold |
| Sep-19-24 | Resumed | UBS | Neutral |
| Sep-05-24 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-04-24 | Downgrade | UBS | Neutral → Sell |
| Feb-14-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-11-23 | Downgrade | Citigroup | Buy → Neutral |
| Dec-12-22 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-14-22 | Upgrade | UBS | Sell → Neutral |
| Sep-19-22 | Initiated | Citigroup | Neutral |
| Jul-20-22 | Initiated | UBS | Sell |
| Jun-17-22 | Resumed | JP Morgan | Neutral |
| Feb-22-22 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-22-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-12-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-26-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Mar-08-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-22-18 | Reiterated | Barclays | Overweight |
| Jan-04-18 | Upgrade | CL King | Neutral → Buy |
| Sep-19-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jul-18-17 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jul-18-17 | Upgrade | William Blair | Mkt Perform → Outperform |
| Apr-25-17 | Reiterated | Canaccord Genuity | Hold |
| Feb-17-17 | Initiated | CL King | Neutral |
| Dec-16-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jun-13-16 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Feb-18-16 | Reiterated | Barclays | Overweight |
| Feb-09-16 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jan-08-16 | Reiterated | Canaccord Genuity | Buy |
| Dec-14-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-02-15 | Initiated | Barclays | Overweight |
| Jul-31-13 | Reiterated | Canaccord Genuity | Buy |
| Mar-03-11 | Downgrade | Wedbush | Outperform → Neutral |
View All
Quidelortho Corporation Stock (QDEL) Latest News
QuidelOrtho reports preliminary Q1 2026 revenue of $615-620 million - StreetInsider
Weaker flu season weighs on QuidelOrtho as Q1 sales fall below $620M - Stock Titan
QuidelOrtho Corp. Stock Plummets to New 52-Week Low at $14.00 - Markets Mojo
QuidelOrtho Corp. Hits Day Low at $14 Amid Price Pressure - Markets Mojo
QuidelOrtho Corp (QDEL) Shares Surge 7.7% -- What GF Score of 63 Tells Investors - GuruFocus
Volatility Watch: Is QuidelOrtho Corporation a defensive stockMarket Activity Summary & Precise Trade Entry Recommendations - baoquankhu1.vn
QuidelOrtho, Lifotronic Technology to Expand Global Immunoassay Portfolio - Medical Product Outsourcing
Today's Analyst Rating Update for QuidelOrtho (QDEL) | QDEL Stoc - GuruFocus
UBS cuts Quidel stock price target on weaker respiratory season By Investing.com - Investing.com India
UBS cuts Quidel stock price target on weaker respiratory season - Investing.com
UBS Adjusts Price Target on QuidelOrtho to $17 From $30, Maintains Neutral Rating - marketscreener.com
UBS Maintains QuidelOrtho(QDEL.US) With Hold Rating, Cuts Target Price to $17 - Moomoo
QuidelOrtho (QDEL) Is Down 18.0% After Proposed NIH Funding Cuts Raised Diagnostics Demand Questions - Sahm
Quidel Corporation stock hits 52-week low at 14.43 USD By Investing.com - Investing.com Australia
QuidelOrtho (QDEL) Is Down 7.6% After Proposed US Health Funding Cuts Raise Policy Uncertainty - Yahoo Finance
Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories stocks trade down, what you need to know - MSN
Assessing QuidelOrtho (QDEL) Valuation After Recent Share Price Volatility - Yahoo Finance
Weekly Earnings: Will QuidelOrtho Corporation benefit from rising consumer demandMarket Performance Report & Consistent Growth Equity Picks - baoquankhu1.vn
How does QuidelOrtho Corporation compare to its peers2026 Trading Recap & Long-Term Capital Growth Strategies - baoquankhu1.vn
Is It Time To Reassess QuidelOrtho (QDEL) After The Recent Share Price Slump? - simplywall.st
QuidelOrtho Corporation (QDEL) stock price, news, quote and history - Yahoo Finance UK
QuidelOrtho Corp (QDEL) Trading Down 5.04% on Apr 6 - GuruFocus
Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know - Yahoo Finance
QuidelOrtho (NASDAQ:QDEL) Shares Down 3.6%Should You Sell? - MarketBeat
QuidelOrtho Corporation (QDEL) Stock Price, News, Quote & History - Yahoo! Finance Canada
QuidelOrtho Corporation $QDEL Shares Sold by JPMorgan Chase & Co. - MarketBeat
QuidelOrtho (NASDAQ:QDEL) Rating Increased to Buy at Wall Street Zen - MarketBeat
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell shares are falling, what you need to know - MSN
QuidelOrtho Corp Stock: Navigating Diagnostics Leadership Amid Sector Evolution and Investor Opportu - AD HOC NEWS
Aug Final Week: Is QuidelOrtho Corporation a defensive stock2026 Trading Volume Trends & Accurate Buy Signal Alerts - baoquankhu1.vn
Buyback Watch: Why is QuidelOrtho Corporation stock going downWeekly Trend Report & Real-Time Price Movement Reports - baoquankhu1.vn
QuidelOrtho Corporation (QDEL) Stock forecasts - Yahoo Finance UK
QuidelOrtho Corp. Stock Plummets to New 52-Week Low of $14.45 - Markets Mojo
Value Recap: Does QuidelOrtho Corporation offer margin of safetyMarket Growth Report & Verified Stock Trade Ideas - baoquankhu1.vn
QuidelOrtho Corp. Stock Plummets to New 52-Week Low of $17.08 - Markets Mojo
Precision Trading with Quidelortho Corp Com (QDEL) Risk Zones - Stock Traders Daily
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know - Yahoo Finance
Vanguard disaggregates holdings; reports 0 shares of QuidelOrtho (QDEL) - Stock Titan
QuidelOrtho (NASDAQ:QDEL) Reaches New 12-Month LowHere's What Happened - MarketBeat
Why is QuidelOrtho (QDEL) down 24.5% since last earnings report? - MSN
QuidelOrtho Corporation (QDEL) Stock Forecasts - Yahoo Finance
QuidelOrtho Corporation (NASDAQ:QDEL) Given Average Recommendation of "Reduce" by Brokerages - MarketBeat
Medtech business QuidelOrtho hires STAAR Surgical legal head as CLO - The Global Legal Post
QuidelOrtho names Nathaniel Sisitsky as chief legal officer By Investing.com - Investing.com Australia
Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer - Sahm
QuidelOrtho Announces Chief Legal Officer Leadership Transition - The Globe and Mail
QuidelOrtho (QDEL) Welcomes New Chief Legal Officer - GuruFocus
In Vitro Diagnostics Firm QuidelOrtho Picks New Legal Chief - Bloomberg Law News
QuidelOrtho Corporation Announces Chief Legal Officer Changes - marketscreener.com
QuidelOrtho names Nathaniel Sisitsky as chief legal officer - investing.com
QuidelOrtho Corp. Hits Day Low of $16.16 Amid Price Pressure - Markets Mojo
Quidelortho Corporation Stock (QDEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.40%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):